C4 Therapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.benzinga_article·Aug 11 at 11:58 AMCCCC-3.64%
C4 Therapeutics grants new hire stock options for 162,880 shares under Nasdaq inducement rulePUBT·Aug 10 at 03:01 PMCCCC-3.64%
C4 Therapeutics shareholders approve amendment to 2020 stock incentive plan evergreen provisionPUBT·Jun 24 at 03:22 PMCCCC-3.64%
Top Biotech Gainers: REPL On Track, SNSE Awaits Phase 2 Data, Keep An Eye On CCCC, IMRX Soarsrttnews·May 31 at 09:33 PMCMND+10.23%REPL-1.29%
C4 Therapeutics Realigns Finance Leadership After Officer DepartureTip Ranks·May 15 at 04:12 PMCCCC-3.64%IBB+0.05%
Vishay Intertechnology, Eos Energy Enterprises, Tower Semiconductor And Other Big Stocks Moving Higher On Wednesdaybenzinga_article·May 13 at 10:31 AMCCCC-3.64%EOSEW+6.91%
